Form 4: ESQ CFO Michael Lacapria Sells Shares for Tax Purposes
Insider Transaction Report
Esquire Financial Holdings CFO Michael Lacapria reported the disposition of 180 common shares at $107 each to cover tax liabilities related to restricted stock vesting.
Summary
- Michael Lacapria, SVP & Chief Financial Officer of Esquire Financial Holdings, Inc. (ESQ), reported a transaction on December 19, 2025.
- 180 shares of Common Stock were disposed of at a price of $107 per share.
- This disposition was coded as 'F', indicating it was for the payment of tax liability incident to the vesting of restricted stock.
- Following this transaction, Mr. Lacapria directly owns 16,442 shares of Common Stock and indirectly owns 3,250 shares via an IRA.
- The filing also details various stock options held by Mr. Lacapria, with exercise prices ranging from $20.85 to $48.32 and expiration dates up to December 15, 2033.
- Several restricted stock grants are mentioned, with vesting schedules extending to January 30, 2028.
Sentiment
Score: 5
Explanation: The filing reports a routine insider transaction for tax purposes, which is neutral in sentiment regarding the company's operational performance or future prospects.
Positives
- The transaction price of $107 per share for the disposed common stock reflects a strong valuation for Esquire Financial Holdings, Inc.
- The significant holdings of common stock (16,442 direct, 3,250 indirect) and various stock options demonstrate strong alignment of management's interests with shareholders.
Negatives
- No direct negatives related to company performance or outlook are indicated by this routine tax-related transaction.
Risks
- No specific risks related to the company's operations or financial health are disclosed in this Form 4 filing.
Future Outlook
This Form 4 filing is a mandatory disclosure of an insider transaction and does not contain forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This filing is a routine insider transaction disclosure and does not provide information relevant to broader industry trends or competitive analysis.
Stakeholder Impact
- Shareholders: The transaction is a routine tax-related sale by a key executive, which is a common occurrence and generally has minimal direct impact on shareholder value beyond the immediate market reaction to the volume of shares. The CFO's continued significant equity holdings align his interests with shareholders.
- Employees: No direct impact on employees is mentioned in this filing.
Next Steps
- Continued vesting of restricted stock in three equal annual installments, with various commencement dates up to January 30, 2028.
- Continued vesting of 2,500 stock options granted on December 15, 2024, in three equal annual installments.
Key Dates
| Date | Description |
|---|---|
| 12/10/2019 | Date exercisable for 1,500 stock options, which are fully vested. |
| 12/16/2021 | Date exercisable for 2,500 stock options, which are fully vested. |
| 12/09/2022 | Date exercisable for 2,500 stock options, which are fully vested. |
| 12/19/2023 | Date exercisable for 2,500 stock options, which are fully vested; Commencement of first annual installment vesting for certain restricted stock. |
| 12/15/2024 | Date exercisable for 2,500 stock options, which vest in three equal annual installments commencing on this date; Commencement of first annual installment vesting for certain restricted stock. |
| 12/09/2025 | Commencement of first annual installment vesting for certain restricted stock. |
| 12/19/2025 | Date of reported transaction (disposition of 180 common shares); Commencement of first annual installment vesting for certain restricted stock. |
| 12/23/2025 | Signature date of the reporting person (pursuant to power of attorney). |
| 12/19/2026 | Commencement of first annual installment vesting for certain restricted stock. |
| 12/15/2027 | Commencement of first annual installment vesting for certain restricted stock. |
| 01/30/2028 | Commencement of first annual installment vesting for certain restricted stock. |
| 12/10/2028 | Expiration date for 1,500 stock options. |
| 12/16/2030 | Expiration date for 2,500 stock options. |
| 12/09/2031 | Expiration date for 2,500 stock options. |
| 12/19/2032 | Expiration date for 2,500 stock options. |
| 12/15/2033 | Expiration date for 2,500 stock options. |
Recommendation
holdThis Form 4 filing details a routine, mandatory insider transaction by the CFO to cover tax liabilities associated with restricted stock vesting. It does not provide new information regarding the company's financial performance, strategic direction, or operational health that would warrant a change in investment recommendation. The CFO retains significant equity holdings, indicating continued alignment with shareholder interests. Therefore, a 'hold' recommendation is appropriate as the fundamental investment thesis remains unchanged based on this filing.
Keywords
Esquire Financial Holdings, ESQ, Michael Lacapria, CFO, Insider Transaction, Stock Sale, Form 4, Restricted Stock, Stock Options, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.